Mice with in vivo OPG deficiency develop osteoporosis, characterized by a reduction in total bone mass and bone density.[72–74] Conversely, mouse and rodent models with low in vivo RANKL expression and sufficient OPG levels exhibit higher total bone mass, greater bone density, and enhanced bone strength.[75]. The gene discussed is TNFSF11; the disease is osteoporosis.